Detection of EGFR Somatic Mutations in Non-Small Cell Lung Cancer (NSCLC) Using a Novel Mutant-Enriched Liquidchip (MEL) Technology

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|13|7|1007-1011

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.7, 2012-09, pp. : 1007-1011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-enriched Sequencing in Chinese Patients with Advanced Non-small Cell Lung Cancer

By Jiang B   Liu F   Yang L   Zhang W   Yuan H   Wang J   Huang G  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1392-1401

Field House Publishing

Access to resources Recommend Favorite

Developmental antiangiogenic agents for the treatment of Non-Small Cell Lung Cancer (NSCLC)

By Blumenschein George  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1802-1811

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to “Work it Out”?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-01 ,pp. : 3863-3874

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-01 ,pp. : 1263-1272

Bentham Science Publishers

Access to resources Recommend Favorite

Role of EGFR Monoclonal Antibodies in the Management of Non–small Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 15, Iss. 9, 2015-11 ,pp. : 792-802

Bentham Science Publishers

Access to resources Recommend Favorite